Roux Jean-François, Pagé Pierre, Dubuc Marc, Thibault Bernard, Guerra Peter G, Macle Laurent, Roy Denis, Talajic Mario, Khairy Paul
Electrophysiology Service, Department of Cardiology, Montreal Heart Institute, Montreal, Canada.
Pacing Clin Electrophysiol. 2007 Feb;30(2):214-20. doi: 10.1111/j.1540-8159.2007.00652.x.
Paralleling the rise in pacemaker and defibrillator implantations, lead extraction procedures are increasingly required. Concerns regarding failure and complications remain.
A total of 200 lead extraction procedures were performed at the Montreal Heart Institute between September 2000 and August 2005. In 23 patients, all leads were removed by traction with a locking stylet. A total of 270 leads were extracted using a laser sheath system (Spectranectics, Colorado Springs, CO, USA) in 177 procedures involving 175 patients (74% male), age 62+/-16 years. Procedural indications were: infection 88 (50%), dysfunction 54 (30%), upgrade 21 (12%), and other 14 (8%). Overall, 241 leads (89%) were successfully extracted, 7 (3%) were partially extracted (< or = 4 cm retained), and 22 (8%) were non-extractable. In multivariate analyses, predictors of failed extraction were longer time from implant (OR 1.16 per year, P=0.0001) and history of hypertension (OR 5.2, P=0.0023). Acute complications occurred in 14 of 177 procedures (7.9%): 8 (4.5%) minor and 6 (3.4%) major, with one death. In multivariate analyses, the only predictor of acute complications was laser lead extraction from both right and left sides during the same procedure (OR 9.4, P = 0.0119). In addition, 3 of 10 patients with failed or partially extracted infected systems eventually required open chest explantation because of endocarditis.
Most leads not amenable to manual traction may be successfully extracted by a percutaneous laser sheath system. While most complications are minor, major complications including death may occur. Older leads are at higher risk for failed extraction. Endocarditis may ensue if infected leads are incompletely removed.
随着起搏器和除颤器植入数量的增加,导线拔除手术的需求也日益增多。对手术失败和并发症的担忧依然存在。
2000年9月至2005年8月期间,蒙特利尔心脏研究所共进行了200例导线拔除手术。23例患者通过使用锁定探针牵引成功拔除了所有导线。在177例手术(涉及175例患者,男性占74%,年龄62±16岁)中,共使用激光鞘系统(美国科罗拉多州斯普林斯市的Spectranectics公司生产)拔除了270根导线。手术适应证包括:感染88例(50%)、功能障碍54例(30%)、升级21例(12%)以及其他14例(8%)。总体而言,241根导线(89%)成功拔除,7根(3%)部分拔除(保留长度≤4 cm),22根(8%)无法拔除。多因素分析显示,导线植入时间较长(每年OR值为1.16,P = 0.0001)和有高血压病史(OR值为5.2,P = 0.0023)是拔除失败的预测因素。177例手术中有14例(7.9%)发生急性并发症:8例(4.5%)为轻度并发症,6例(3.4%)为重度并发症,其中1例死亡。多因素分析显示,同一手术中从左右两侧进行激光导线拔除是急性并发症的唯一预测因素(OR值为9.4,P = 0.0119)。此外,10例导线拔除失败或部分拔除的感染系统患者中有3例最终因心内膜炎需要进行开胸取出术。
大多数无法通过手动牵引拔除的导线可通过经皮激光鞘系统成功拔除。虽然大多数并发症为轻度,但可能发生包括死亡在内的重度并发症。植入时间较长的导线拔除失败风险较高。如果感染的导线未完全拔除,可能会引发心内膜炎。